(Q33572005)

28 July 2017

3 references

21 March 2019

25 June 2019

26 October 2020

Update on potential medical treatments for encapsulating peritoneal sclerosis; human and experimental data (English)

1 reference

sclerosing encapsulating peritonitis

28 July 2017

3 references

21 March 2019

25 June 2019

26 October 2020

immunosuppressive drug

1 reference

26 October 2020

Tom Cornelis

1

1 reference

PubMed ID

20449655

28 July 2017

Dimitrios G Oreopoulos

series ordinal

2

1 reference

28 July 2017

7 May 2010

1 reference

PubMed ID

20449655

International Urology and Nephrology

28 July 2017

1 March 2011

3 references

21 March 2019

25 June 2019

26 October 2020

4 references

28 July 2017

21 March 2019

25 June 2019

26 October 2020

43

1 reference

28 July 2017

1

1 reference

28 July 2017

147-156

1 reference

Biological markers in the peritoneal dialysate effluent: are they useful

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Tamoxifen therapy for encapsulating peritoneal sclerosis: mechanism of action and update on clinical experiences

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Experimental encapsulating peritoneal sclerosis models: pathogenesis and treatment.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Encapsulating peritoneal sclerosis--a clinician's approach to diagnosis and medical treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Glucose degradation products (GDP's) and peritoneal changes in patients on chronic peritoneal dialysis: will new dialysis solutions prevent these changes?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Morphological and functional changes in the dialysed peritoneal cavity: impact of more biocompatible solutions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis. Inhibition of basic fibroblast growth factor and platelet-derived growth factor action and antagonism of rapamycin by FK506.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.

21 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9744-5

Corticosteroid therapy in encapsulating peritoneal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9744-5

Acute-onset, steroid-sensitive, encapsulating peritoneal sclerosis in a renal transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9744-5

Prednisolone inhibits hyperosmolarity-induced expression of MCP-1 via NF-kappaB in peritoneal mesothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9744-5

Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9744-5

The ACE inhibitor, quinapril, ameliorates peritoneal fibrosis in an encapsulating peritoneal sclerosis model in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9744-5

A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9744-5

Prognostic role of serum ACE activity on outcome of type 2 diabetic patients on chronic ambulatory peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9744-5

Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9744-5

Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9744-5

TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9744-5

Prolonged use of the tyrosine kinase inhibitor in a peritoneal dialysis patient with metastatic renal cell carcinoma: possible beneficial effects on peritoneal membrane and peritonitis rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9744-5

The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-010-9744-5

Peritoneal dialysis patients with high effluent fibrin degradation products

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Computed tomographic findings characteristic for encapsulating peritoneal sclerosis: a case-control study.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Does immunosuppressive treatment ameliorate morphology changes in encapsulating peritoneal sclerosis?

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Can N-acetylcysteine preserve peritoneal function and morphology in encapsulating peritoneal sclerosis?

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

The effects of colchicine on the progression and regression of encapsulating peritoneal sclerosis.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Experimental study on long-term exposure to a biocompatible, hypertonic, pyruvate-buffered dialysis solution.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

The effects of renin-angiotensin system inhibition on regression of encapsulating peritoneal sclerosis.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Fibrin degradation products are a useful marker for the risk of encapsulating peritoneal sclerosis.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Role of the renin-angiotensin system in the pathogenesis of peritoneal fibrosis.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Recommendation of the surgical option for treatment of encapsulating peritoneal sclerosis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Hepatocyte growth factor prevents peritoneal fibrosis in an animal model of encapsulating peritoneal sclerosis.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Serum beta2 microglobulin (beta2MG) level is a potential predictor for encapsulating peritoneal sclerosis (EPS) in peritoneal dialysis patients.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Tgf-beta1 induced by high glucose is controlled by angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on cultured human peritoneal mesothelial cells.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Successful treatment of encapsulating peritoneal sclerosis with azathioprine and prednisolone.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Angiotensin II mediates high glucose-induced TGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Clinical experience with tamoxifen in peritoneal fibrosing syndromes

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

Glucocorticoid protects against the development of encapsulating peritoneal sclerosis on peritoneal dialysis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3061214

The use of biocompatible solutions does not prevent development of encapsulating peritoneal sclerosis

31 October 2018

1 reference

12 December 2020

No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis

1 reference

12 December 2020

Early diagnostic markers for encapsulating peritoneal sclerosis: a case-control study

1 reference

12 December 2020

Sclerosing encapsulating peritonitis: a case successfully treated with immunosuppression

1 reference

12 December 2020

Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study

1 reference

12 December 2020

Immunosuppression in sclerosing peritonitis

1 reference

12 December 2020

A case of a dialysis patient with sclerosing peritonitis successfully treated with corticosteroid therapy alone

1 reference

12 December 2020

Biocompatibility of a peritoneal dialysis solution with amino acids: histological evaluation in the rabbit

1 reference

12 December 2020

Oxidative stress during peritoneal dialysis: implications in functional and structural changes in the membrane

1 reference

12 December 2020

Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma is expressed by rat peritoneal mesothelial cells: its potential role in peritoneal cavity local defense

1 reference

12 December 2020

Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model

1 reference

12 December 2020

[Development of gene therapy for encapsulating peritoneal sclerosis by a chimeric DNA-RNA hammerhead ribozyme targeting TGF-beta1 mRNA]

1 reference

12 December 2020

Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis

1 reference

12 December 2020

Increasing incidence of severe encapsulating peritoneal sclerosis after kidney transplantation

1 reference

12 December 2020

Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats

1 reference

12 December 2020

The Role of the TGF/Smad Signaling Pathway in Peritoneal Fibrosis Induced by Peritoneal Dialysis Solutions

1 reference

12 December 2020

Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis

1 reference

12 December 2020

10.1007/S11255-010-9744-5

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

PubMed ID

20449655